Personalised medicine in MS: A step forward.
In the world of MS where each medicine works for some patients and not others this is really important. Specially having collateral effects into account.
An Important but Limited Step Forward in Personalized Multiple Sclerosis Care
Dr. Robert Fox puts a tissue marker study in context
https://consultqd.clevelandclinic.org/a ... osis-care/
Treatment of relapsing-remitting multiple sclerosis (MS) in 2018 remains far from what can be described as personalized medicine, but an important initial step toward more personalized management of MS relapses has been achieved by researchers with University Medical Center Goettingen in Germany.
So contends Cleveland Clinic neurologist Robert Fox, MD, in an editorial accompanying the German study published online by JAMA Neurology on February 5, 2018.